Fig. 2From: The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patientsAMIGO2 expression is negatively correlated with prognosis of patients with gastric cancer. a Kaplan–Meier analysis of overall survival in gastric cancer patients with high (> 70% staining intensity) vs. low (≤ 70%) AMIGO2 expression. Differences between the survival curves were examined using the log‑rank test. b Kaplan–Meier analysis of disease-specific survival in gastric cancer patients with high (> 70% staining intensity) vs. low (≤ 70%) AMIGO2 expression. Differences between the survival curves were examined using the log‑rank testBack to article page